Equities / Sectors / Healthcare
Healthcare
#6 by market capPharmaceuticals, biotechnology, medical devices and care providers. 565 US-listed equities across 10 industries; the sector accounts for 9.3% of tracked equity market cap and 11.2% of daily volume.
Market cap
$7.703T
-0.46%
-$35.763B · 1D
Sector weight
9.3%
of tracked market cap
Volume 24h
$79.694B
11.2% of market volume
Revenue TTM
$4.184T
Sum of constituents
Net income TTM
$153.576B
3.7% net margin
P/E (TTM)
49.9×
Market 30.4×
Dividend yield
1.7%
Market 1.3%
Employees
4.4M
Across 565 companies
Industry breakdown
Share of sector market cap · 10 industries
Concentration
Share of sector market cap by constituent
HHI index
395.9
Mega caps
7
Median cap
$1.372B
Valuation vs. market
Sector totals valued as one company; marker is the all-equities median
P/E (TTM): 49.9× · market 20.1×
P/S: 1.8× · market 2.7×
EV / EBITDA: 19.2× · market 12.9×
Operating margin: 7.9% · market 8.5%
Dividend yield: 1.7% · market 2.3%
Trading at a 63.9% P/E premium to the all-equities market.
Returns vs. market
Cap-weighted price return · spread in percentage points
| Period | Sector | Market | Spread |
|---|---|---|---|
| 1 day | -0.46% | -0.49% | +0.03% |
| 1 week | +0.59% | +1.37% | -0.78% |
| 1 month | -0.38% | +0.52% | -0.90% |
| 3 months | +1.73% | +1.79% | -0.06% |
| Year to date | +8.94% | +12.39% | -3.45% |
| 1 year | +17.15% | +13.52% | +3.63% |
Constituents
565 equities
Eli Lilly and Company LLY · US | Drug Manufacturers - General | $1.043T | 13.5% | $1.17K | -1.61% | +1.72% | +4.07% | $3.615B | 39× |
Johnson & Johnson JNJ · US | Drug Manufacturers - General | $617.662B | 8% | $256.48 | -0.76% | -0.84% | -4.70% | $1.583B | 29.4× |
AbbVie Inc. ABBV · US | Drug Manufacturers - General | $481.385B | 6.2% | $272.42 | +0.39% | +4.81% | +9.50% | $1.496B | 76.8× |
Merck & Co., Inc. MRK · US | Drug Manufacturers - General | $351.635B | 4.6% | $142.38 | -0.29% | -0.99% | -4.10% | $1.197B | 39.4× |
UnitedHealth Group Inc. UNH · US | Healthcare Plans | $335.71B | 4.4% | $370.95 | -1.34% | +1.57% | -7.46% | $2.701B | 23.8× |
Thermo Fisher Scientific Inc. TMO · US | Diagnostics & Research | $242.29B | 3.1% | $651.98 | -1.52% | -0.08% | +8.12% | $1.686B | 35.4× |
Amgen Inc. Common Stock AMGN · US | Drug Manufacturers - General | $220.262B | 2.9% | $407.44 | -1.37% | +0.04% | +3.63% | $968.93M | 25.2× |
Gilead Sciences, Inc. GILD · US | Drug Manufacturers - General | $182.551B | 2.4% | $147.10 | +0.17% | -0.27% | +0.31% | $660.41M | -56.3× |
Abbott Laboratories ABT · US | Medical Devices | $171.551B | 2.2% | $98.49 | -0.24% | +1.86% | -6.66% | $1.37B | 27.3× |
Pfizer Inc. PFE · US | Drug Manufacturers - General | $158.546B | 2.1% | $27.82 | -0.64% | -1.07% | +0.11% | $1.233B | 21.2× |
Danaher Corp. DHR · US | Diagnostics & Research | $152.853B | 2% | $217.46 | -0.47% | +2.69% | +5.96% | $1.151B | 38.2× |
Intuitive Surgical Inc. ISRG · US | Medical Instruments & Supplies | $147.014B | 1.9% | $415.41 | +0.21% | +3.53% | +18.63% | $1.052B | 46.8× |
| Biotechnology | $127.497B | 1.7% | $503.25 | -0.47% | -0.69% | -4.85% | $748.84M | 28.9× | |
Bristol-Myers Squibb Company BMY · US | Drug Manufacturers - General | $121.647B | 1.6% | $59.58 | -0.20% | -3.06% | -7.90% | $778.75M | 13.1× |
Medtronic plc MDT · US | Medical Devices | $112.324B | 1.5% | $87.75 | +2.62% | +1.52% | -5.02% | $9.272B | 21.5× |
CVS Health Corporation Common Stock CVS · US | Healthcare Plans | $112.208B | 1.5% | $87.80 | -0.17% | +3.05% | -8.61% | $685.64M | 23× |
McKesson Corporation MCK · US | Medical Distribution | $111.63B | 1.4% | $930.25 | +2.19% | +3.50% | +4.63% | $665.69M | 23.4× |
Stryker Corp. SYK · US | Medical Devices | $106.238B | 1.4% | $276.97 | +0.57% | +1.47% | +0.20% | $826.04M | 28.5× |
HCA Healthcare, Inc. HCA · US | Medical Care Facilities | $96.996B | 1.3% | $445.01 | +1.33% | +5.11% | +10.69% | $501.66M | 14.2× |
Elevance Health, Inc. ELV · US | Healthcare Plans | $87.152B | 1.1% | $400.94 | -0.83% | +5.05% | -0.25% | $315.06M | 16.6× |
Moderna Inc. MRNA · US | Biotechnology | $78.603B | 1% | $197 | +0.26% | +4.27% | +40.38% | $7.365B | -25× |
Regeneron Pharmaceuticals, Inc. REGN · US | Biotechnology | $77.668B | 1% | $739.57 | -0.34% | +0.65% | -8.73% | $370.01M | 17.6× |
The Cigna Group CI · US | Healthcare Plans | $74.089B | 1% | $281.03 | +0.90% | +4.88% | +1.89% | $436.38M | 11.6× |
Cencora Inc. COR · US | Medical Distribution | $61.322B | 0.8% | $321.35 | +1.29% | +3.74% | -1.03% | $288.44M | 23.4× |
Boston Scientific Corp. BSX · US | Medical Devices | $60.82B | 0.8% | $42.04 | +1.11% | -2.75% | -6.54% | $961.6M | 16.6× |